97 related articles for article (PubMed ID: 12960829)
21. Cervical cancer incidence after up to 20 years of observation among women with HIV.
Massad LS; Hessol NA; Darragh TM; Minkoff H; Colie C; Wright RL; Cohen M; Seaberg EC
Int J Cancer; 2017 Oct; 141(8):1561-1565. PubMed ID: 28670714
[TBL] [Abstract][Full Text] [Related]
22. Increased risk of cervical abnormalities among HIV-infected African women.
Folkers G
NIAID AIDS Agenda; 1996 Jun; ():9, 11. PubMed ID: 11363811
[TBL] [Abstract][Full Text] [Related]
23. Association of infections with human immunodeficiency virus and human papillomavirus in Honduras.
Ferrera A; Melchers WJ; Velema JP; Figueroa M
Am J Trop Med Hyg; 1997 Aug; 57(2):138-41. PubMed ID: 9288804
[TBL] [Abstract][Full Text] [Related]
24. Epidemiology of Cervical Squamous Intraepithelial Lesions in HIV Infected Women in Kenya: a cross-Sectional Study.
Memiah P; Makokha V; Mbuthia W; Kiiru GW; Agbor S; Odhiambo F; Ojoo S; Mbizo J; Muhula S; Mahasi G; Biadgilign S
Afr J Reprod Health; 2015 Mar; 19(1):133-9. PubMed ID: 26103703
[TBL] [Abstract][Full Text] [Related]
25. Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection.
van Aardt MC; Dreyer G; Pienaar HF; Karlsen F; Hovland S; Richter KL; Becker P
Int J Gynecol Cancer; 2015 Jun; 25(5):919-25. PubMed ID: 25950128
[TBL] [Abstract][Full Text] [Related]
26. Age at diagnosis of preinvasive and invasive cervical neoplasia in South Africa: HIV-positive versus HIV-negative women.
van Bogaert LJ
Int J Gynecol Cancer; 2011 Feb; 21(2):363-6. PubMed ID: 21270617
[TBL] [Abstract][Full Text] [Related]
27. High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study.
Lei J; Ploner A; Lagheden C; Eklund C; Nordqvist Kleppe S; Andrae B; Elfström KM; Dillner J; Sparén P; Sundström K
PLoS Med; 2018 Oct; 15(10):e1002666. PubMed ID: 30273338
[TBL] [Abstract][Full Text] [Related]
28. Screening patterns within organized programs and survival of Italian women with invasive cervical cancer.
Zucchetto A; Ronco G; Giorgi Rossi P; Zappa M; Ferretti S; Franzo A; Falcini F; Visioli CB; Zanetti R; Biavati P; La Rosa F; Baracco S; Federico M; Campari C; De Togni A; Piffer S; Pannozzo F; Fusco M; Michiara M; Castaing M; Seghini P; Tisano F; Serraino D;
Prev Med; 2013 Sep; 57(3):220-6. PubMed ID: 23732239
[TBL] [Abstract][Full Text] [Related]
29. Incidence of invasive cervical cancer in a cohort of HIV-seropositive women before and after the introduction of highly active antiretroviral therapy.
Dorrucci M; Suligoi B; Serraino D; Tirelli U; Rezza G;
J Acquir Immune Defic Syndr; 2001 Apr; 26(4):377-80. PubMed ID: 11317082
[TBL] [Abstract][Full Text] [Related]
30. Analysis of the Prevalence of HTLV-1 Proviral DNA in Cervical Smears and Carcinomas from HIV Positive and Negative Kenyan Women.
He X; Maranga IO; Oliver AW; Gichangi P; Hampson L; Hampson IN
Viruses; 2016 Sep; 8(9):. PubMed ID: 27608036
[TBL] [Abstract][Full Text] [Related]
31. Cancer incidence in women with or at risk for HIV.
Phelps RM; Smith DK; Heilig CM; Gardner LI; Carpenter CC; Klein RS; Jamieson DJ; Vlahov D; Schuman P; Holmberg SD;
Int J Cancer; 2001 Dec; 94(5):753-7. PubMed ID: 11745473
[TBL] [Abstract][Full Text] [Related]
32. Long-term incidence of cervical cancer in women with human immunodeficiency virus.
Massad LS; Seaberg EC; Watts DH; Minkoff H; Levine AM; Henry D; Colie C; Darragh TM; Hessol NA
Cancer; 2009 Feb; 115(3):524-30. PubMed ID: 19127538
[TBL] [Abstract][Full Text] [Related]
33. Effect of HIV infection on atypical squamous cells of undetermined significance.
Duerr A; Paramsothy P; Jamieson DJ; Heilig CM; Klein RS; Cu-Uvin S; Schuman P; Anderson JR;
Clin Infect Dis; 2006 Mar; 42(6):855-61. PubMed ID: 16477565
[TBL] [Abstract][Full Text] [Related]
34. Invasive cervical cancer in human immunodeficiency virus-infected and uninfected hospital patients.
Chin KM; Sidhu JS; Janssen RS; Weber JT
Obstet Gynecol; 1998 Jul; 92(1):83-7. PubMed ID: 9649099
[TBL] [Abstract][Full Text] [Related]
35. The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research.
Klein RS; Flanigan T; Schuman P; Smith D; Vlahov D
Int J Tuberc Lung Dis; 1999 Aug; 3(8):681-8. PubMed ID: 10460100
[TBL] [Abstract][Full Text] [Related]
36. Human Immunodeficiency Virus (HIV)- and Non-HIV-Associated Immunosuppression and Risk of Cervical Neoplasia.
Silverberg MJ; Leyden WA; Chi A; Gregorich S; Huchko MJ; Kulasingam S; Kuppermann M; Seto A; Smith-McCune KK; Sawaya GF
Obstet Gynecol; 2018 Jan; 131(1):47-55. PubMed ID: 29215531
[TBL] [Abstract][Full Text] [Related]
37. Advancing age and cervical cancer screening and prognosis.
Sawaya GF; Sung HY; Kearney KA; Miller M; Kinney W; Hiatt RA; Mandelblatt J
J Am Geriatr Soc; 2001 Nov; 49(11):1499-504. PubMed ID: 11890589
[TBL] [Abstract][Full Text] [Related]
38. Limited impact of immunosuppression and HAART on the incidence of cervical squamous intraepithelial lesions in HIV-positive women.
Heard I; Potard V; Costagliola D
Antivir Ther; 2006; 11(8):1091-6. PubMed ID: 17302379
[TBL] [Abstract][Full Text] [Related]
39. A cross-sectional study of high-risk human papillomavirus clustering and cervical outcomes in HIV-infected women in Rio de Janeiro, Brazil.
Castilho JL; Levi JE; Luz PM; Cambou MC; Vanni T; de Andrade A; Derrico M; Veloso VG; Grinsztejn B; Friedman RK
BMC Cancer; 2015 Jun; 15():478. PubMed ID: 26100400
[TBL] [Abstract][Full Text] [Related]
40. The impact of human immunodeficiency virus infection on pelvic inflammatory disease: a case-control study in Abidjan, Ivory Coast.
Kamenga MC; De Cock KM; St Louis ME; Touré CK; Zakaria S; N'gbichi JM; Ghys PD; Holmes KK; Eschenbach DA; Gayle HD
Am J Obstet Gynecol; 1995 Mar; 172(3):919-25. PubMed ID: 7892886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
